www.mayflowerbio.com
Sales & Support: 314-485-5210

*

Obatoclax

Supplier:
Catalogue number:
10-2660-01
Size:
5 mg
Product is available in:
  • USA
  • Canada
$70.00 Shipping is calculated in checkout

BCL-2 antagonist; Induces apoptosis / A novel Bcl-2 homology domain-3 (BH3) mimetic1. Inhibits primary acute myeloid leukemia (AML) progenitor cell proliferation (IC50=0.18 μM) and induces apoptosis in primary AML cells (IC50= 3.6 μM)2. Synergizes with other agents such as chloroquine3 and cytarabine4 in cytotoxicity against a variety of cancer cells.

Product Type:

Biochemicals & reagents

CAS Number:

803712-79-0

Alternative Names:

GX15-070

Reference:

1) Chonghaile and Letai (2008), Mimicking the BH3 domain to kill cancer cells; Oncogene, 27 S149 2) Konopleva et al. (2008), Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax); Cancer Res., 68 3413 3) Wang et al. (2014), Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells; Oncol. Rep., 32 2789 4) Xie et al. (2015), Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage; Mol. Oncol., 9 409

Storage Temperature:

-20°C

Additional Information:

TARGET: Bcl-2 -- PATHWAY: Apoptosis inducer; Proliferation; Necroptosis; Autophagy; Mitochondrial function; Bcl -- RESEARCH AREA: Cell death -- DISEASE AREA: Cancer